1. Home
  2. Nation
  3. Serum Institute to start production of Russia’s ‘Sputnik V’ covid vaccine soon

Serum Institute to start production of Russia’s ‘Sputnik V’ covid vaccine soon

By Saima Siddiqui 
Updated Date
Serum Institute to start production of Russia’s ‘Sputnik V’ covid vaccine soon

New Delhi: The developers of Russia’s ‘Sputnik V’ Covid-19 vaccine and India’s Serum Institute announced plans on Tuesday to start producing ‘Sputnik V’ vaccine in India in September.

Also Read :- Indonesia’s Covid-19 toll breaches 1 lakh mark; 1,747 deaths in last 24 hrs

Russia’s sovereign wealth fund, which is promoting the vaccine globally, said the plan was to produce over 300 million doses of the vaccine per year in India, the leading production hub for Sputnik V.

“The parties intend to produce over 300 million doses of the vaccine in India per year with the first batch expected in September 2021,” the Russian Direct Investment Fund (RDIF) said in a statement.

SII, the world’s largest vaccine manufacturer by volume, has already received cell and vector samples from Russia’s Gamaleya Centre, RDIF said.

“With their import approved by the Drug Controller General of India (DCGI), the cultivation process has begun,” RDIF said in a statement.

Also Read :- Covid 2nd wave still raging, R-value up in 8 states, UTs; Govt calls it cause of concern

India is the leading production hub for production of Sputnik vaccine. RDIF had earlier reached agreements with a number of pharmaceutical companies in India (Gland Pharma, Hetero Biopharma, Panacea Biotec, Stelis Biopharma, Virchow Biotech and Morepen) for production of the Russian vaccine.

“To date, Russian Sputnik V vaccine has been registered in 67 countries globally with a total population of over 3.5 bn people. The data obtained by regulators of a number of countries during the vaccination of the population, including in Argentina, Serbia, Bahrain, Hungary, Mexico, San Marino, UAE and others, demonstrates that Sputnik V is one of the safest and most effective vaccines against coronavirus,” RDIF said.

Further reading:
For the latest news and reviews, follow us on Facebook and Twitter ...
X